Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Royalty Income Nonoperating

Royalty Income Nonoperating at other companies

Utah Medical Products logo
Utah Medical ProductsUTMD
$5K+33.3%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$12K—
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$854K+2.5%
Lightwave Logic, Inc. logo
Lightwave Logic, Inc.LWLG
$50K—
Helix Energy Solutions Group logo
Helix Energy Solutions GroupHLX
$1.69M+19.2%
Carter's logo
Carter'sCRI
$4.53M-6.0%

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:RoyaltyIncomeNonoperating.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's royalty income nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's royalty income nonoperating?
Utah Medical Products (UTMD) reported royalty income nonoperating of $5K in Q4 2025.
How has Utah Medical Products's royalty income nonoperating changed year-over-year?
Utah Medical Products's royalty income nonoperating increased by 33.3% year-over-year, from $3.75K to $5K.
What is the long-term trend for Utah Medical Products's royalty income nonoperating?
Over 4 years (2021 to 2025), Utah Medical Products's royalty income nonoperating has grown at a 7.5% compound annual growth rate (CAGR), from $15K to $20K.
What does royalty income nonoperating mean?
Represents revenue derived from licensing intellectual property or proprietary technology to third parties. It serves as a measure of the value of the company's patent portfolio and its ability to monetize innovation without direct manufacturing involvement.